Vezocolmitide (ST-100; Stuart Therapeutics) is a collagen mimetic peptide (CMP) therapy designed to seek out and repair ...
A Recently Completed Dry Eye Disease Field Trial, which Was Numerically Supportive of Reproxalap and Consistent with Prior Field Trials, Did Not Reach Statistical Significance, and Is Expected to be ...
Honey's antibacterial benefits are widely recognised but now a QUT team of optometry researchers is conducting clinical trials of the therapeutic effect of the sweet nectar as a remedy for dry, red ...
The U.S. Food and Drug Administration (FDA) on Thursday issued a Complete Response Letter for Aldeyra Therapeutics, Inc.’s (NASDAQ:ALDX) resubmission of the New Drug Application (NDA) of reproxalap, ...
Reproxalap 0.25% was superior to vehicle-control on ocular discomfort symptom score from 80 to 100 minutes after chamber entry. Reproxalap ophthalmic solution 0.25% reached the primary endpoint in a ...
Interested in Aldeyra Therapeutics, Inc.? Here are five stocks we like better. Aldeyra Therapeutics is awaiting near-term FDA feedback on its dry eye drug reproxalap after a third complete response ...
LEXINGTON, Mass.--(BUSINESS WIRE)-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced it will host a webcast and conference call on Tuesday, May 6, 2025, at 8:00 a.m. ET to announce ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Dry eye disease associated with systemic autoimmune or ...
New research links menopause with more severe dry eye and points to hormonal changes affecting the tears and glands that ...
Health and Me on MSN
Postmenopausal women may face more severe dry eye disease; how do hormones contribute?
A recent study says that women undergoing menopause are at a higher risk of developing dry eye disease compared to other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results